Patents by Inventor Michael Wellesley Whitehouse

Michael Wellesley Whitehouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of C5a receptor antagonist in the treatment of fibrosis
    Patent number: 7919459
    Abstract: This invention relates to the use of an antagonist of a G protein-coupled receptor in the prevention and/or treatment of fibrosis, such as the treatment of fibrosis associated with myocardial infarction or diabetes or certain pulmonary conditions. In a preferred embodiment, the antagonist is a C5a receptor antagonist, more preferably a cyclic peptide antagonist of the C5a receptor. In particular, the invention provides a method of prevention, treatment or alleviation of a fibrotic condition, comprising the step of administering an effective amount of an antagonist of a G protein-coupled receptor to a subject in need of such treatment.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: April 5, 2011
    Assignee: Promics Pty Limited
    Inventors: Stephen Maxwell Taylor, Ian Alexander Shiels, Lindsay Charles Brown, Michael Wellesley Whitehouse
  • Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
    Patent number: 6761913
    Abstract: Biologically active extracts of celery seed are produced by controlled ethanolic extraction, distillation and drying, and further processing by supercritical fluid extractions (SFE), and may be further fractionated by column fractionation, distillation, LiAlH reduction and the like. These extracts possess activity for the treatment and prevention of acute and chronic pain, inflammation and gastrointestinal irritation.
    Type: Grant
    Filed: April 22, 2003
    Date of Patent: July 13, 2004
    Assignee: International Celery Development Alliance PTY. Ltd.
    Inventors: Desley Ethel Butters, Craig Kendall Charles Davis, Ross Peter McGeary, Michael Christopher Powanda, Kim Drummond Rainsford, Michael Wellesley Whitehouse
  • Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
    Publication number: 20030206980
    Abstract: Biologically active extracts of celery seed are produced by controlled ethanolic extraction, distillation and drying, and further processing by supercritical fluid extractions (SFE), and may be further fractionated by column fractionation, distillation, LiAlH reduction and the like. These extracts possess activity for the treatment and prevention of acute and chronic pain, inflammation and gastrointestinal irritation.
    Type: Application
    Filed: April 22, 2003
    Publication date: November 6, 2003
    Inventors: Desley Ethel Butters, Craig Kendall Charles Davis, Ross Peter McGeary, Michael Christopher Powanda, Kim Drummond Rainsford, Michael Wellesley Whitehouse
  • Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
    Patent number: 6576274
    Abstract: Biologically active extracts of celery seed are produced by controlled ethanolic extraction, distillation and drying, and further processing by supercritical fluid extractions (SFE), and may be further fractionated by column fractionation, distillation, LiAlH reduction and the like. These extracts possess activity for the treatment and prevention of acute and chronic pain, inflammation and gastrointestinal irritation.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: June 10, 2003
    Assignee: International Celery Development Alliance Pty. LTD
    Inventors: Desley Ethel Butters, Craig Kendall Charles Davis, Ross Peter McGeary, Michael Christopher Powanda, Kim Drummond Rainsford, Michael Wellesley Whitehouse
  • Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
    Publication number: 20020081343
    Abstract: Biologically active extracts of celery seed are produced by controlled ethanolic extraction, distillation and drying, and further processing by supercritical fluid extractions (SFE), and may be further fractionated by column fractionation, distillation, LiAlH reduction and the like. These extracts possess activity for the treatment and prevention of acute and chronic pain, inflammation and gastrointestinal irritation.
    Type: Application
    Filed: October 26, 2001
    Publication date: June 27, 2002
    Inventors: Desley Ethel Butters, Craig Kendall Charles Davis, Ross Peter McGeary, Michael Christopher Powanda, Kim Drummond Rainsford, Michael Wellesley Whitehouse
  • Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
    Patent number: 6352728
    Abstract: Biologically active extracts of celery seed are produced by controlled ethanolic extraction, distillation and drying, and further processing by supercritical fluid extractions (SFE), and may be further fractionated by column fractionation, distillation, LiAIH reduction and the like. These extracts possess activity for the treatment and prevention of acute and chronic pain, inflammation and gastrointestinal irritation.
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: March 5, 2002
    Assignee: International Celery Development Alliance Pty. Ltd.
    Inventors: Desley Ethel Butters, Craig Kendall Charles Davis, Ross Peter McGeary, Michael Christopher Powanda, Kim Drummond Rainsford, Michael Wellesley Whitehouse